James Parsons
Chairman
DiaMedica Therapeutics Inc. (DMAC)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About James Parsons
James Parsons is recorded as Chairman at DiaMedica Therapeutics Inc. (DMAC). DiaMedica Therapeutics Inc. reported in an 8-K filed May 23, 2024 that James Parsons was appointed Director, effective May 22, 2024.
“The seven director nominees proposed by the Board were elected to serve as members of the Board until the next annual general meeting of shareholders and until their respective successors are duly elected and qualified by the following final voting results”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Start not stated–2024-04-04
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at DiaMedica Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- Rick Pauls CEO, Board Member
- Charles Semba Board Member
- Charles Semba, M.D. Board Member
- Daniel J. O'Connor Board Member
- Daniel O’Connor Board Member
- Michael Giuffre Board Member
- Michael Giuffre, M.D. Board Member
- Richard E. Kuntz, M.D., M.Sc. Board Member
- Richard Kuntz Board Member
- Richard Kuntz, M.D., M.Sc. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.